A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Cutting down a tree can be quite an arduous undertaking, and how to kill a tree stump is a bit of a mystery. But if a tree is long in the tooth (or…branch?) and threatens to fall over, cut down it ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Not all trees drop their leaves in the fall. Even in the height of winter ...

The pace of AI continues to be staggering. From simple pattern recognition systems to large language models (LLMs), and now as we move into the physical AI reality, the power of these systems ...

Severe cold temperatures hitting much of the country this week could branch out − literally. As people brace for the winter weather, some social media posts in recent days have warned of the chance ...

A new VS Code extension called Nogic visualizes codebases as interactive graphs and drew strong interest on Hacker News. Commenters praised the concept for understanding large or unfamiliar codebases, ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. This rainforest tree solved one of evolution’s hardest ...

The lights are dimming on this year's Rockefeller Center Christmas Tree. The 11-ton Norway Spruce is getting its last hours of gilded glory before crews bring it down to be milled and repurposed ...

The rising costs of labor and equipment are trickling down to homeowners who need to call “timber!” By Dan Levin What is removing a tree worth? Quotes vary widely, depending on size, risk and ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...